Sign in

Filings

Finds words inside filing documents. Searching Aprea Therapeutics, Inc.'s filings · 55 documents indexed.

23 documents · 60 matches

  1. APRE Aprea Therapeutics, Inc. 10-K 2026-03-16

    Item 1A. Risk Factors

    going concern may cause others to choose not to deal with us due to concerns about our ability to meet
    13 matches in this document

  2. APRE Aprea Therapeutics, Inc. 10-Q 2025-11-12

    Item 1A. Risk Factors

    going concern may cause others to choose not to deal with us due to concerns about our ability to meet
    9 matches in this document

  3. APRE Aprea Therapeutics, Inc. 10-Q 2025-08-12

    Item 1A. Risk Factors

    going concern may cause others to choose not to deal with us due to concerns about our ability to meet
    9 matches in this document

  4. APRE Aprea Therapeutics, Inc. 10-Q 2025-05-14

    Item 1A. Risk Factors

    going concern may cause others to choose not to deal with us due to concerns about our ability to meet
    9 matches in this document

  5. APRE Aprea Therapeutics, Inc. 10-Q 2026-11-04

    Item 1 · Note 1. Nature of business and basis of presentation

    going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business
    1 match in this document

  6. APRE Aprea Therapeutics, Inc. 10-Q 2026-08-12

    Item 1 · Note 1. Nature of business and basis of presentation

    going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business
    1 match in this document

  7. APRE Aprea Therapeutics, Inc. 10-Q 2026-05-13

    Item 1 · Note 1. Nature of business and basis of presentation

    going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business
    2 matches in this document

  8. APRE Aprea Therapeutics, Inc. 8-K 2026-03-30

    going concern, and the other risks, uncertainties, and other factors described under “Risk Factors,” “Management’s Discussion and Analysis of Financial
    1 match in this document

  9. APRE Aprea Therapeutics, Inc. 8-K 2026-03-30

    going concern, and the other risks, uncertainties, and other factors described under “Risk Factors,” “Management’s Discussion and Analysis of Financial
    1 match in this document

  10. APRE Aprea Therapeutics, Inc. 8-K 2026-03-16

    going concern, and the other risks, uncertainties, and other factors described under “Risk Factors,” “Management’s Discussion and Analysis of Financial
    1 match in this document

  11. APRE Aprea Therapeutics, Inc. 8-K 2026-03-16

    going concern, and the other risks, uncertainties, and other factors described under “Risk Factors,” “Management’s Discussion and Analysis of Financial
    1 match in this document

  12. APRE Aprea Therapeutics, Inc. 8-K 2026-02-18

    going concern, and the other risks, uncertainties, and other factors described under “Risk Factors,” “Management’s Discussion and Analysis of Financial
    1 match in this document

  13. APRE Aprea Therapeutics, Inc. 8-K 2026-01-29

    going concern, and the other risks, uncertainties, and other factors described under “Risk Factors,” “Management’s Discussion and Analysis of Financial
    1 match in this document

  14. APRE Aprea Therapeutics, Inc. 8-K 2026-01-29

    going concern, and the other risks, uncert ainties, and other factors described under “Risk Factors,” “Management’s Discussion and Analysis
    1 match in this document

  15. APRE Aprea Therapeutics, Inc. 8-K 2026-01-09

    going concern, and the other risks, uncertainties, and other factors described under “Risk Factors,” “Management’s Discussion and Analysis of Financial
    1 match in this document

  16. APRE Aprea Therapeutics, Inc. 8-K 2025-11-12

    going concern, and the other risks, uncertainties, and other factors described under “Risk Factors,” “Management’s Discussion and Analysis of Financial
    1 match in this document

  17. APRE Aprea Therapeutics, Inc. 8-K 2025-11-12

    going concern, and the other risks, uncertainties, and other factors described under “Risk Factors,” “Management’s Discussion and Analysis of Financial
    1 match in this document

  18. APRE Aprea Therapeutics, Inc. 8-K 2025-10-24

    going concern, and the other risks, uncertainties, and other factors described under “Risk Factors,” “Management’s Discussion and Analysis of Financial
    1 match in this document

  19. APRE Aprea Therapeutics, Inc. 8-K 2025-10-15

    going concern, and the other risks, uncertainties, and other factors described under “Risk Factors,” “Management’s Discussion and Analysis of Financial
    1 match in this document

  20. APRE Aprea Therapeutics, Inc. 8-K 2025-10-15

    going concern, and the other risks, uncertainties, and other factors described under “Risk Factors,” “Management’s Discussion and Analysis of Financial
    1 match in this document

Page 1 of 2 · 23 documents